Global Foot and Mouth Disease (FMD) Vaccines Market Insights and Forecast to 2027

Publisher Name :
Date: 11-May-2021
No. of pages: 145
Inquire Before Buying

Foot and Mouth Disease (FMD) Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Foot and Mouth Disease (FMD) Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type

- Emergency Vaccines

- Conventional Vaccines

Segment by Application

- Cattle

- Pig

- Sheep & Goat

- Others

By Company

- Jinyu Group

- Cavet Bio

- Indian Immunologicals

- Tecon Group

- CAHIC

- Shen Lian

- Biogenesis Bagó

- BIGVET Biotech

- Boehringer Ingelheim

- MSD Animal Health

- CEVA

- FGBI

- Bayer HealthCare

- Brilliant Bio Pharma

- VECOL

- Sanofi (Merial)

- VETAL

- BVI

- LIMOR

- ME VAC

- Agrovet

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

Global Foot and Mouth Disease (FMD) Vaccines Market Insights and Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Foot and Mouth Disease (FMD) Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Foot and Mouth Disease (FMD) Vaccines Market Size Growth Rate by Type
1.4.2 Emergency Vaccines
1.4.3 Conventional Vaccines
1.3 Market by Application
1.3.1 Global Foot and Mouth Disease (FMD) Vaccines Market Size Growth Rate by Application
1.3.2 Cattle
1.3.3 Pig
1.3.4 Sheep & Goat
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Estimates and Forecasts 2016-2027
2.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue Estimates and Forecasts 2016-2027
2.3 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Foot and Mouth Disease (FMD) Vaccines Regions by Sales
2.4.1 Global Top Foot and Mouth Disease (FMD) Vaccines Regions by Sales (2016-2021)
2.4.2 Global Top Foot and Mouth Disease (FMD) Vaccines Regions by Sales (2022-2027)
2.5 Global Top Foot and Mouth Disease (FMD) Vaccines Regions by Revenue
2.5.1 Global Top Foot and Mouth Disease (FMD) Vaccines Regions by Revenue (2016-2021)
2.5.2 Global Top Foot and Mouth Disease (FMD) Vaccines Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Manufacturers
3.1.1 Global Top Foot and Mouth Disease (FMD) Vaccines Manufacturers by Sales (2016-2021)
3.1.2 Global Top Foot and Mouth Disease (FMD) Vaccines Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Foot and Mouth Disease (FMD) Vaccines Sales in 2020
3.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Manufacturers
3.2.1 Global Top Foot and Mouth Disease (FMD) Vaccines Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Foot and Mouth Disease (FMD) Vaccines Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Foot and Mouth Disease (FMD) Vaccines Revenue in 2020
3.3 Global Foot and Mouth Disease (FMD) Vaccines Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Foot and Mouth Disease (FMD) Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Foot and Mouth Disease (FMD) Vaccines Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Type
4.1.1 Global Foot and Mouth Disease (FMD) Vaccines Historical Sales by Type (2016-2021)
4.1.2 Global Foot and Mouth Disease (FMD) Vaccines Forecasted Sales by Type (2022-2027)
4.1.3 Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2016-2027)
4.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Type
4.2.1 Global Foot and Mouth Disease (FMD) Vaccines Historical Revenue by Type (2016-2021)
4.2.2 Global Foot and Mouth Disease (FMD) Vaccines Forecasted Revenue by Type (2022-2027)
4.2.3 Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Type (2016-2027)
4.3 Global Foot and Mouth Disease (FMD) Vaccines Price by Type
4.3.1 Global Foot and Mouth Disease (FMD) Vaccines Price by Type (2016-2021)
4.3.2 Global Foot and Mouth Disease (FMD) Vaccines Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Application
5.1.1 Global Foot and Mouth Disease (FMD) Vaccines Historical Sales by Application (2016-2021)
5.1.2 Global Foot and Mouth Disease (FMD) Vaccines Forecasted Sales by Application (2022-2027)
5.1.3 Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2016-2027)
5.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Application
5.2.1 Global Foot and Mouth Disease (FMD) Vaccines Historical Revenue by Application (2016-2021)
5.2.2 Global Foot and Mouth Disease (FMD) Vaccines Forecasted Revenue by Application (2022-2027)
5.2.3 Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Application (2016-2027)
5.3 Global Foot and Mouth Disease (FMD) Vaccines Price by Application
5.3.1 Global Foot and Mouth Disease (FMD) Vaccines Price by Application (2016-2021)
5.3.2 Global Foot and Mouth Disease (FMD) Vaccines Price Forecast by Application (2022-2027)
6 North America
6.1 North America Foot and Mouth Disease (FMD) Vaccines Market Size by Type
6.1.1 North America Foot and Mouth Disease (FMD) Vaccines Sales by Type (2016-2027)
6.1.2 North America Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2016-2027)
6.2 North America Foot and Mouth Disease (FMD) Vaccines Market Size by Application
6.2.1 North America Foot and Mouth Disease (FMD) Vaccines Sales by Application (2016-2027)
6.2.2 North America Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2016-2027)
6.3 North America Foot and Mouth Disease (FMD) Vaccines Market Size by Country
6.3.1 North America Foot and Mouth Disease (FMD) Vaccines Sales by Country (2016-2027)
6.3.2 North America Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Foot and Mouth Disease (FMD) Vaccines Market Size by Type
7.1.1 Europe Foot and Mouth Disease (FMD) Vaccines Sales by Type (2017-2027)
7.1.2 Europe Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2017-2027)
7.2 Europe Foot and Mouth Disease (FMD) Vaccines Market Size by Application
7.2.1 Europe Foot and Mouth Disease (FMD) Vaccines Sales by Application (2017-2027)
7.2.2 Europe Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2017-2027)
7.3 Europe Foot and Mouth Disease (FMD) Vaccines Market Size by Country
7.3.1 Europe Foot and Mouth Disease (FMD) Vaccines Sales by Country (2017-2027)
7.3.2 Europe Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Market Size by Type
8.1.1 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales by Type (2018-2027)
8.1.2 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2018-2027)
8.2 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Market Size by Application
8.2.1 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales by Application (2018-2027)
8.2.2 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2018-2027)
8.3 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Market Size by Region
8.3.1 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales by Region (2018-2027)
8.3.2 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Foot and Mouth Disease (FMD) Vaccines Market Size by Type
9.1.1 Latin America Foot and Mouth Disease (FMD) Vaccines Sales by Type (2019-2027)
9.1.2 Latin America Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2019-2027)
9.2 Latin America Foot and Mouth Disease (FMD) Vaccines Market Size by Application
9.2.1 Latin America Foot and Mouth Disease (FMD) Vaccines Sales by Application (2019-2027)
9.2.2 Latin America Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2019-2027)
9.3 Latin America Foot and Mouth Disease (FMD) Vaccines Market Size by Country
9.3.1 Latin America Foot and Mouth Disease (FMD) Vaccines Sales by Country (2019-2027)
9.3.2 Latin America Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
6 Middle East and Africa
6.1 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Market Size by Type
6.1.1 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales by Type (2016-2027)
6.1.2 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2016-2027)
6.2 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Market Size by Application
6.2.1 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales by Application (2016-2027)
6.2.2 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2016-2027)
6.3 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Market Size by Country
6.3.1 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales by Country (2016-2027)
6.3.2 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 U.A.E
11 Company Profiles
11.1 Jinyu Group
11.1.1 Jinyu Group Corporation Information
11.1.2 Jinyu Group Overview
11.1.3 Jinyu Group Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Jinyu Group Foot and Mouth Disease (FMD) Vaccines Product Description
11.1.5 Jinyu Group Related Developments
11.2 Cavet Bio
11.2.1 Cavet Bio Corporation Information
11.2.2 Cavet Bio Overview
11.2.3 Cavet Bio Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Cavet Bio Foot and Mouth Disease (FMD) Vaccines Product Description
11.2.5 Cavet Bio Related Developments
11.3 Indian Immunologicals
11.3.1 Indian Immunologicals Corporation Information
11.3.2 Indian Immunologicals Overview
11.3.3 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Product Description
11.3.5 Indian Immunologicals Related Developments
11.4 Tecon Group
11.4.1 Tecon Group Corporation Information
11.4.2 Tecon Group Overview
11.4.3 Tecon Group Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Tecon Group Foot and Mouth Disease (FMD) Vaccines Product Description
11.4.5 Tecon Group Related Developments
11.5 CAHIC
11.5.1 CAHIC Corporation Information
11.5.2 CAHIC Overview
11.5.3 CAHIC Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 CAHIC Foot and Mouth Disease (FMD) Vaccines Product Description
11.5.5 CAHIC Related Developments
11.6 Shen Lian
11.6.1 Shen Lian Corporation Information
11.6.2 Shen Lian Overview
11.6.3 Shen Lian Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Shen Lian Foot and Mouth Disease (FMD) Vaccines Product Description
11.6.5 Shen Lian Related Developments
11.7 Biogenesis Bagó
11.7.1 Biogenesis Bagó Corporation Information
11.7.2 Biogenesis Bagó Overview
11.7.3 Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Product Description
11.7.5 Biogenesis Bagó Related Developments
11.8 BIGVET Biotech
11.8.1 BIGVET Biotech Corporation Information
11.8.2 BIGVET Biotech Overview
11.8.3 BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Product Description
11.8.5 BIGVET Biotech Related Developments
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Corporation Information
11.9.2 Boehringer Ingelheim Overview
11.9.3 Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Product Description
11.9.5 Boehringer Ingelheim Related Developments
11.10 MSD Animal Health
11.10.1 MSD Animal Health Corporation Information
11.10.2 MSD Animal Health Overview
11.10.3 MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Product Description
11.10.5 MSD Animal Health Related Developments
11.1 Jinyu Group
11.1.1 Jinyu Group Corporation Information
11.1.2 Jinyu Group Overview
11.1.3 Jinyu Group Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Jinyu Group Foot and Mouth Disease (FMD) Vaccines Product Description
11.1.5 Jinyu Group Related Developments
11.12 FGBI
11.12.1 FGBI Corporation Information
11.12.2 FGBI Overview
11.12.3 FGBI Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
11.12.4 FGBI Product Description
11.12.5 FGBI Related Developments
11.13 Bayer HealthCare
11.13.1 Bayer HealthCare Corporation Information
11.13.2 Bayer HealthCare Overview
11.13.3 Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
11.13.4 Bayer HealthCare Product Description
11.13.5 Bayer HealthCare Related Developments
11.14 Brilliant Bio Pharma
11.14.1 Brilliant Bio Pharma Corporation Information
11.14.2 Brilliant Bio Pharma Overview
11.14.3 Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
11.14.4 Brilliant Bio Pharma Product Description
11.14.5 Brilliant Bio Pharma Related Developments
11.15 VECOL
11.15.1 VECOL Corporation Information
11.15.2 VECOL Overview
11.15.3 VECOL Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
11.15.4 VECOL Product Description
11.15.5 VECOL Related Developments
11.16 Sanofi (Merial)
11.16.1 Sanofi (Merial) Corporation Information
11.16.2 Sanofi (Merial) Overview
11.16.3 Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
11.16.4 Sanofi (Merial) Product Description
11.16.5 Sanofi (Merial) Related Developments
11.17 VETAL
11.17.1 VETAL Corporation Information
11.17.2 VETAL Overview
11.17.3 VETAL Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
11.17.4 VETAL Product Description
11.17.5 VETAL Related Developments
11.18 BVI
11.18.1 BVI Corporation Information
11.18.2 BVI Overview
11.18.3 BVI Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
11.18.4 BVI Product Description
11.18.5 BVI Related Developments
11.19 LIMOR
11.19.1 LIMOR Corporation Information
11.19.2 LIMOR Overview
11.19.3 LIMOR Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
11.19.4 LIMOR Product Description
11.19.5 LIMOR Related Developments
11.20 ME VAC
11.20.1 ME VAC Corporation Information
11.20.2 ME VAC Overview
11.20.3 ME VAC Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
11.20.4 ME VAC Product Description
11.20.5 ME VAC Related Developments
11.21 Agrovet
11.21.1 Agrovet Corporation Information
11.21.2 Agrovet Overview
11.21.3 Agrovet Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
11.21.4 Agrovet Product Description
11.21.5 Agrovet Related Developments
12 Value Chain and Sales Channels Analysis
12.1 Foot and Mouth Disease (FMD) Vaccines Value Chain Analysis
12.2 Foot and Mouth Disease (FMD) Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Foot and Mouth Disease (FMD) Vaccines Production Mode & Process
12.4 Foot and Mouth Disease (FMD) Vaccines Sales and Marketing
12.4.1 Foot and Mouth Disease (FMD) Vaccines Sales Channels
12.4.2 Foot and Mouth Disease (FMD) Vaccines Distributors
12.5 Foot and Mouth Disease (FMD) Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Foot and Mouth Disease (FMD) Vaccines Industry Trends
13.2 Foot and Mouth Disease (FMD) Vaccines Market Drivers
13.3 Foot and Mouth Disease (FMD) Vaccines Market Challenges
13.4 Foot and Mouth Disease (FMD) Vaccines Market Restraints
14 Key Findings in The Global Foot and Mouth Disease (FMD) Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Foot and Mouth Disease (FMD) Vaccines Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Emergency Vaccines
Table 3. Major Manufacturers of Conventional Vaccines
Table 4. Global Foot and Mouth Disease (FMD) Vaccines Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 5. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Foot and Mouth Disease (FMD) Vaccines Sales by Region (2016-2021) & (K L)
Table 7. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Region (2016-2021)
Table 8. Global Foot and Mouth Disease (FMD) Vaccines Sales by Region (2016-2021) & (K L)
Table 9. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Region (2022-2027)
Table 10. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 11. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Region (2016-2021)
Table 12. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Region (2022-2027) & (US$ Million)
Table 13. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Region (2022-2027)
Table 14. Global Foot and Mouth Disease (FMD) Vaccines Sales by Manufacturers (2016-2021) & (K L)
Table 15. Global Foot and Mouth Disease (FMD) Vaccines Sales Share by Manufacturers (2016-2021)
Table 16. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 17. Global Foot and Mouth Disease (FMD) Vaccines Revenue Share by Manufacturers (2016-2021)
Table 18. Foot and Mouth Disease (FMD) Vaccines Price by Manufacturers 2016-2021 (USD/L)
Table 19. Global Foot and Mouth Disease (FMD) Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Foot and Mouth Disease (FMD) Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Foot and Mouth Disease (FMD) Vaccines as of 2020)
Table 21. Foot and Mouth Disease (FMD) Vaccines Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Foot and Mouth Disease (FMD) Vaccines Product Offered
Table 23. Date of Manufacturers Enter into Foot and Mouth Disease (FMD) Vaccines Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Foot and Mouth Disease (FMD) Vaccines Sales by Type (2016-2021) & (K L)
Table 26. Global Foot and Mouth Disease (FMD) Vaccines Sales by Type (2022-2027) & (K L)
Table 27. Global Foot and Mouth Disease (FMD) Vaccines Sales Share by Type (2016-2021)
Table 28. Global Foot and Mouth Disease (FMD) Vaccines Sales Share by Type (2022-2027)
Table 29. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2016-2021) & (US$ Million)
Table 30. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2022-2027) & (US$ Million)
Table 31. Global Foot and Mouth Disease (FMD) Vaccines Revenue Share by Type (2016-2021)
Table 32. Global Foot and Mouth Disease (FMD) Vaccines Revenue Share by Type (2022-2027)
Table 33. Foot and Mouth Disease (FMD) Vaccines Price by Type (2016-2021) & (USD/L)
Table 34. Global Foot and Mouth Disease (FMD) Vaccines Price Forecast by Type (2022-2027) & (USD/L)
Table 35. Global Foot and Mouth Disease (FMD) Vaccines Sales by Application (2016-2021) & (K L)
Table 36. Global Foot and Mouth Disease (FMD) Vaccines Sales by Application (2022-2027) & (K L)
Table 37. Global Foot and Mouth Disease (FMD) Vaccines Sales Share by Application (2016-2021)
Table 38. Global Foot and Mouth Disease (FMD) Vaccines Sales Share by Application (2022-2027)
Table 39. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2016-2021) & (US$ Million)
Table 40. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2022-2027) & (US$ Million)
Table 41. Global Foot and Mouth Disease (FMD) Vaccines Revenue Share by Application (2016-2021)
Table 42. Global Foot and Mouth Disease (FMD) Vaccines Revenue Share by Application (2022-2027)
Table 43. Foot and Mouth Disease (FMD) Vaccines Price by Application (2016-2021) & (USD/L)
Table 44. Global Foot and Mouth Disease (FMD) Vaccines Price Forecast by Application (2022-2027) & (USD/L)
Table 45. North America Foot and Mouth Disease (FMD) Vaccines Sales by Type (2016-2021) & (K L)
Table 46. North America Foot and Mouth Disease (FMD) Vaccines Sales by Type (2022-2027) & (K L)
Table 47. North America Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2016-2021) & (US$ Million)
Table 48. North America Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2022-2027) & (US$ Million)
Table 49. North America Foot and Mouth Disease (FMD) Vaccines Sales by Application (2016-2021) & (K L)
Table 50. North America Foot and Mouth Disease (FMD) Vaccines Sales by Application (2022-2027) & (K L)
Table 51. North America Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2016-2021) & (US$ Million)
Table 52. North America Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2022-2027) & (US$ Million)
Table 53. North America Foot and Mouth Disease (FMD) Vaccines Sales by Country (2016-2021) & (K L)
Table 54. North America Foot and Mouth Disease (FMD) Vaccines Sales by Country (2022-2027) & (K L)
Table 55. North America Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 56. North America Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2022-2027) & (US$ Million)
Table 57. Europe Foot and Mouth Disease (FMD) Vaccines Sales by Type (2016-2021) & (K L)
Table 58. Europe Foot and Mouth Disease (FMD) Vaccines Sales by Type (2022-2027) & (K L)
Table 59. Europe Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2016-2021) & (US$ Million)
Table 60. Europe Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2022-2027) & (US$ Million)
Table 61. Europe Foot and Mouth Disease (FMD) Vaccines Sales by Application (2016-2021) & (K L)
Table 62. Europe Foot and Mouth Disease (FMD) Vaccines Sales by Application (2022-2027) & (K L)
Table 63. Europe Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2016-2021) & (US$ Million)
Table 64. Europe Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2022-2027) & (US$ Million)
Table 65. Europe Foot and Mouth Disease (FMD) Vaccines Sales by Country (2016-2021) & (K L)
Table 66. Europe Foot and Mouth Disease (FMD) Vaccines Sales by Country (2022-2027) & (K L)
Table 67. Europe Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 68. Europe Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2022-2027) & (US$ Million)
Table 69. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales by Type (2016-2021) & (K L)
Table 70. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales by Type (2022-2027) & (K L)
Table 71. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2016-2021) & (US$ Million)
Table 72. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2022-2027) & (US$ Million)
Table 73. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales by Application (2016-2021) & (K L)
Table 74. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales by Application (2022-2027) & (K L)
Table 75. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2016-2021) & (US$ Million)
Table 76. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2022-2027) & (US$ Million)
Table 77. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales by Region (2016-2021) & (K L)
Table 78. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales by Region (2022-2027) & (K L)
Table 79. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 80. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Revenue by Region (2022-2027) & (US$ Million)
Table 81. Latin America Foot and Mouth Disease (FMD) Vaccines Sales by Type (2016-2021) & (K L)
Table 82. Latin America Foot and Mouth Disease (FMD) Vaccines Sales by Type (2022-2027) & (K L)
Table 83. Latin America Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2016-2021) & (US$ Million)
Table 84. Latin America Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2022-2027) & (US$ Million)
Table 85. Latin America Foot and Mouth Disease (FMD) Vaccines Sales by Application (2016-2021) & (K L)
Table 86. Latin America Foot and Mouth Disease (FMD) Vaccines Sales by Application (2022-2027) & (K L)
Table 87. Latin America Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2016-2021) & (US$ Million)
Table 88. Latin America Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2022-2027) & (US$ Million)
Table 89. Latin America Foot and Mouth Disease (FMD) Vaccines Sales by Country (2016-2021) & (K L)
Table 90. Latin America Foot and Mouth Disease (FMD) Vaccines Sales by Country (2022-2027) & (K L)
Table 91. Latin America Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 92. Latin America Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2022-2027) & (US$ Million)
Table 93. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales by Type (2016-2021) & (K L)
Table 94. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales by Type (2022-2027) & (K L)
Table 95. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2016-2021) & (US$ Million)
Table 96. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2022-2027) & (US$ Million)
Table 97. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales by Application (2016-2021) & (K L)
Table 98. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales by Application (2022-2027) & (K L)
Table 99. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2016-2021) & (US$ Million)
Table 100. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2022-2027) & (US$ Million)
Table 101. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales by Country (2016-2021) & (K L)
Table 102. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales by Country (2022-2027) & (K L)
Table 103. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 104. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2022-2027) & (US$ Million)
Table 105. Jinyu Group Corporation Information
Table 106. Jinyu Group Description and Major Businesses
Table 107. Jinyu Group Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2016-2021)
Table 108. Jinyu Group Foot and Mouth Disease (FMD) Vaccines Product
Table 109. Jinyu Group Recent Developments
Table 110. Cavet Bio Corporation Information
Table 111. Cavet Bio Description and Major Businesses
Table 112. Cavet Bio Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2016-2021)
Table 113. Cavet Bio Foot and Mouth Disease (FMD) Vaccines Product
Table 114. Cavet Bio Recent Developments
Table 115. Indian Immunologicals Corporation Information
Table 116. Indian Immunologicals Description and Major Businesses
Table 117. Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2016-2021)
Table 118. Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Product
Table 119. Indian Immunologicals Recent Developments
Table 120. Tecon Group Corporation Information
Table 121. Tecon Group Description and Major Businesses
Table 122. Tecon Group Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2016-2021)
Table 123. Tecon Group Foot and Mouth Disease (FMD) Vaccines Product
Table 124. Tecon Group Recent Developments
Table 125. CAHIC Corporation Information
Table 126. CAHIC Description and Major Businesses
Table 127. CAHIC Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2016-2021)
Table 128. CAHIC Foot and Mouth Disease (FMD) Vaccines Product
Table 129. CAHIC Recent Developments
Table 130. Shen Lian Corporation Information
Table 131. Shen Lian Description and Major Businesses
Table 132. Shen Lian Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2016-2021)
Table 133. Shen Lian Foot and Mouth Disease (FMD) Vaccines Product
Table 134. Shen Lian Recent Developments
Table 135. Biogenesis Bagó Corporation Information
Table 136. Biogenesis Bagó Description and Major Businesses
Table 137. Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2016-2021)
Table 138. Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Product
Table 139. Biogenesis Bagó Recent Developments
Table 140. BIGVET Biotech Corporation Information
Table 141. BIGVET Biotech Description and Major Businesses
Table 142. BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2016-2021)
Table 143. BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Product
Table 144. BIGVET Biotech Recent Developments
Table 145. Boehringer Ingelheim Corporation Information
Table 146. Boehringer Ingelheim Description and Major Businesses
Table 147. Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2016-2021)
Table 148. Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Product
Table 149. Boehringer Ingelheim Recent Developments
Table 150. MSD Animal Health Corporation Information
  • Global Classical Swine Fever Vaccines Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 100
    It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of The genus Pestivirus of The family Flaviviridae, and is closely related to The viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV). The global Classical Swine Fever Vaccines market was valued at US$ 154.7 million in 2023 and is anticipa......
  • Global Tylosin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96
    According to our LPI (LP Information) latest study, the global Tylosin market size was valued at US$ 674.4 million in 2023. With growing demand in downstream market, the Tylosin is forecast to a readjusted size of US$ 909 million by 2030 with a CAGR of 4.4% during review period. The research report highlights the growth potential of the global Tylosin market. Tylosin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chai......
  • Global Animal Parasiticides Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106
    According to our LPI (LP Information) latest study, the global Animal Parasiticides market size was valued at US$ 6898.6 million in 2023. With growing demand in downstream market, the Animal Parasiticides is forecast to a readjusted size of US$ 9363.4 million by 2030 with a CAGR of 4.5% during review period. The research report highlights the growth potential of the global Animal Parasiticides market. Animal Parasiticides are expected to show stable growth in the future market. However, ......
  • Global Newcastle Disease Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114
    According to our LPI (LP Information) latest study, the global Newcastle Disease Vaccine market size was valued at US$ 308 million in 2023. With growing demand in downstream market, the Newcastle Disease Vaccine is forecast to a readjusted size of US$ 389.8 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Newcastle Disease Vaccine market. Newcastle Disease Vaccine are expected to show stable growth in the future m......
  • Global Classical Swine Fever Vaccines Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 126
    According to our LPI (LP Information) latest study, the global Classical Swine Fever Vaccines market size was valued at US$ 151.4 million in 2023. With growing demand in downstream market, the Classical Swine Fever Vaccines is forecast to a readjusted size of US$ 209.8 million by 2030 with a CAGR of 4.8% during review period. The research report highlights the growth potential of the global Classical Swine Fever Vaccines market. Classical Swine Fever Vaccines are expected to show stable ......
  • Global Veterinary Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 151
    According to our LPI (LP Information) latest study, the global Veterinary Vaccine market size was valued at US$ 10570 million in 2023. With growing demand in downstream market, the Veterinary Vaccine is forecast to a readjusted size of US$ 17200 million by 2030 with a CAGR of 7.2% during review period. The research report highlights the growth potential of the global Veterinary Vaccine market. Veterinary Vaccine are expected to show stable growth in the future market. However, product di......
  • Global Foot and Mouth Disease (FMD) Vaccines Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134
    According to our LPI (LP Information) latest study, the global Foot and Mouth Disease (FMD) Vaccines market size was valued at US$ 895.6 million in 2023. With growing demand in downstream market, the Foot and Mouth Disease (FMD) Vaccines is forecast to a readjusted size of US$ 1644.2 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Foot and Mouth Disease (FMD) Vaccines market. Foot and Mouth Disease (FMD) Vaccines......
  • Global Veterinary Products for Companion Animals Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Veterinary Products for Companion Animals market size was valued at US$ 15190 million in 2023. With growing demand in downstream market, the Veterinary Products for Companion Animals is forecast to a readjusted size of US$ 22710 million by 2030 with a CAGR of 5.9% during review period. The research report highlights the growth potential of the global Veterinary Products for Companion Animals market. Veterinary Products for Co......
  • Global Newcastle Disease Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 115
    According to our (Global Info Research) latest study, the global Newcastle Disease Vaccine market size was valued at USD 323.9 million in 2023 and is forecast to a readjusted size of USD 402.7 million by 2030 with a CAGR of 3.2% during review period. Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans. Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines s......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs